NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
Intradermal administration of the JYNNEOS mpox vaccine is as effective and safe as subcutaneous administration, according to new data released this week by the Centers for Disease Control and ...
An overview of how disease-modifying treatments for Alzheimer disease can impact medical costs and caregiver burden. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the ...